Cite
HARVARD Citation
Lee, C. et al. (2022). Low-dose IL-2 may enhance the effect of vedolizumab. Scandinavian journal of gastroenterology. pp. 1404-1405. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lee, C. et al. (2022). Low-dose IL-2 may enhance the effect of vedolizumab. Scandinavian journal of gastroenterology. pp. 1404-1405. [Online].